Uncategorized - December 26, 2023
JERUSALEM, Dec. 26, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the […]
Read More
Uncategorized - December 26, 2023
Beijing, Dec. 26, 2023 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]
Read More
Uncategorized - December 26, 2023
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B […]
Read More
Uncategorized - December 26, 2023
VANCOUVER, British Columbia, Dec. 26, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biopharmaceutical company developing novel, multifunctional […]
Read More
Uncategorized - December 26, 2023
SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today […]
Read More
Uncategorized - December 26, 2023
Key findings from prospective evaluation of 200 prenatal samples: Optical genome mapping (OGM) detected pathogenic structural variants (SVs) in 20.5% […]
Read More
Uncategorized - December 26, 2023
ROCKAWAY, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today […]
Read More
Uncategorized - December 26, 2023
Investigational Review Board (IRB) approval has been granted for 60 Degrees Pharma’s double-blind, placebo-controlled study to investigate tafenoquine for treatment […]
Read More
Uncategorized - December 26, 2023
TORONTO, Dec. 26, 2023 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces the successful completion […]
Read More
Uncategorized - December 26, 2023
GUANGZHOU, China, Dec. 26, 2023 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading […]
Read More